Rare diseases
Investigational molecules
Locations
Via Alessandro Manzoni 56, 20089 Rozzano, Italy
IRCCS Humanitas Research Hospital in Rozzano, Italy specialises in clinical trials of conditions such as Colitis ulcerative, Non-small cell lung cancer, Crohn's disease, Squamous cell carcinoma of head and neck, and other specialisations. This site conducts important research.
The medical center is at the forefront of nephrology research, focusing on innovative treatments for Idiopathic IgA nephropathy (IgAN). This condition, characterized by the deposition of IgA antibodies in the kidneys, can lead to significant renal impairment.
Through its research, the center aims to refine therapeutic strategies, minimizing the side effects associated with traditional treatments while enhancing patient outcomes. The integration of corticosteroids and SGLT2 inhibitors represents a significant advancement in managing proteinuria in IgAN patients.
Clinical trials currently enrolling participants at this site.
ItalyStudy of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis
ItalyLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
ItalyEvaluation of Anifrolumab Subcutaneous Treatment in Immunosuppressant‑Naïve and Biologic‑Naïve Patients with Systemic Lupus Erythematosus
ItalyLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
ItalyLong-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
ItalyA study to evaluate the safety and effectiveness of HLX43 in patients with advanced non-small cell lung cancer
ItalyA study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.
ItalyA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
ItalyA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
ItalyA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
ItalyStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
ItalyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
